<DOC>
	<DOC>NCT00215397</DOC>
	<brief_summary>The purpose of this study is to determine which dose of the investigational drug is the most safe and effective in the treatment of asthma compared to the control drug.</brief_summary>
	<brief_title>Study in Patients With Asthma</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Formoterol Fumarate</mesh_term>
	<criteria>Patients with a history of asthma Current asthma exacerbation or recent asthma exacerbation, requiring hospitalization History of smoking Debilitating systemic and/or lifethreatening diseases.</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2008</verification_date>
	<keyword>Asthma</keyword>
	<keyword>Formoterol</keyword>
	<keyword>Fumarate</keyword>
</DOC>